negative control sequence Search Results


90
Ribobio co pfn1 sirna
<t>PFN1</t> is correlated with NSCLC metastasis and could promote NSCLC cell migration in vitro . (A) Representative IHC images of PFN1 expression on the NSCLC tissues. (B) The staining index of PFN1 on the tissue chip. ** p < 0.01. (C) Representative IHC images of PFN1 expression on the tissue chip. (D) The expression of PFN1 in TCGA LUAD data. ** p < 0.01. (E) The Kaplan–Meier survival analysis of PFN1 in NSCLC patients. (Data source: TCGA LUAD dataset) (F,G) Wound healing assays conducted to evaluate the migration ability of PFN1 -overexpressing (F) and PFN1 knockdown (KD) (G) H1299 cells. ** p < 0.01; scale bar, 500 μm. (H,I) Transwell migration assays conducted to evaluate the migration of PFN1 -overexpressing (H) and PFN1 KD (I) H1299 cells. ** p < 0.01; scale bar, 500 μm. EV, empty vector; OE, PFN1 overexpression; NC, negative control; si-1/ 2, PFN1 siRNA1 1/2.
Pfn1 Sirna, supplied by Ribobio co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/negative+control+sequence/sirnas+for+pfn1+and+cdc42+knockdown+and+negative+control+sequences++si+nc+/pmc09108340-61-0-10
Average 90 stars, based on 1 article reviews
pfn1 sirna - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma mismatched sequence negative control oligonucleotide
<t>PFN1</t> is correlated with NSCLC metastasis and could promote NSCLC cell migration in vitro . (A) Representative IHC images of PFN1 expression on the NSCLC tissues. (B) The staining index of PFN1 on the tissue chip. ** p < 0.01. (C) Representative IHC images of PFN1 expression on the tissue chip. (D) The expression of PFN1 in TCGA LUAD data. ** p < 0.01. (E) The Kaplan–Meier survival analysis of PFN1 in NSCLC patients. (Data source: TCGA LUAD dataset) (F,G) Wound healing assays conducted to evaluate the migration ability of PFN1 -overexpressing (F) and PFN1 knockdown (KD) (G) H1299 cells. ** p < 0.01; scale bar, 500 μm. (H,I) Transwell migration assays conducted to evaluate the migration of PFN1 -overexpressing (H) and PFN1 KD (I) H1299 cells. ** p < 0.01; scale bar, 500 μm. EV, empty vector; OE, PFN1 overexpression; NC, negative control; si-1/ 2, PFN1 siRNA1 1/2.
Mismatched Sequence Negative Control Oligonucleotide, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/negative+control+sequence/mismatched+sequence+negative+control+oligonucleotide/pm21358675-252-6-14
Average 90 stars, based on 1 article reviews
mismatched sequence negative control oligonucleotide - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma nontargeting sequences (negative control, nc) (pre–nc or anti–nc)
<t>PFN1</t> is correlated with NSCLC metastasis and could promote NSCLC cell migration in vitro . (A) Representative IHC images of PFN1 expression on the NSCLC tissues. (B) The staining index of PFN1 on the tissue chip. ** p < 0.01. (C) Representative IHC images of PFN1 expression on the tissue chip. (D) The expression of PFN1 in TCGA LUAD data. ** p < 0.01. (E) The Kaplan–Meier survival analysis of PFN1 in NSCLC patients. (Data source: TCGA LUAD dataset) (F,G) Wound healing assays conducted to evaluate the migration ability of PFN1 -overexpressing (F) and PFN1 knockdown (KD) (G) H1299 cells. ** p < 0.01; scale bar, 500 μm. (H,I) Transwell migration assays conducted to evaluate the migration of PFN1 -overexpressing (H) and PFN1 KD (I) H1299 cells. ** p < 0.01; scale bar, 500 μm. EV, empty vector; OE, PFN1 overexpression; NC, negative control; si-1/ 2, PFN1 siRNA1 1/2.
Nontargeting Sequences (Negative Control, Nc) (Pre–Nc Or Anti–Nc), supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/negative+control+sequence/non+targeting+sequence++negative+control++nc+/pm30945454-351-10-22
Average 90 stars, based on 1 article reviews
nontargeting sequences (negative control, nc) (pre–nc or anti–nc) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma negative control mir sequences
Upregulation of <t>miR-150</t> suppresses human papillary thyroid carcinoma cell proliferation and metastasis. (A) Relative miR-150 expression in TPC-1 cells following transfection. (B) Proliferation of TPC-1 cells following transfection. (C) Representative micrographs of a wound-healing assay in TPC-1 cells following transfection (Scale bars=50 µm). (D) Representative micrographs of Transwell invasion experiments in TPC-1 cells following transfection (Scale bars=50 µm). (E) Statistical analysis of the wound-healing assay results. (F) Statistical analysis of the Transwell invasion assay results. *P<0.05 vs. mimic-Con, **P<0.01 vs. mimic-Con. miR-150, microRNA-150; mimic-Con, <t>negative</t> <t>control</t> transfection; OD, optical density.
Negative Control Mir Sequences, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/negative+control+sequence/negative+control+mir+sequences/pmc05995047-33-4-12
Average 90 stars, based on 1 article reviews
negative control mir sequences - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma lentiviruses designed for overexpressing mettl16 and senp3
Upregulation of <t>miR-150</t> suppresses human papillary thyroid carcinoma cell proliferation and metastasis. (A) Relative miR-150 expression in TPC-1 cells following transfection. (B) Proliferation of TPC-1 cells following transfection. (C) Representative micrographs of a wound-healing assay in TPC-1 cells following transfection (Scale bars=50 µm). (D) Representative micrographs of Transwell invasion experiments in TPC-1 cells following transfection (Scale bars=50 µm). (E) Statistical analysis of the wound-healing assay results. (F) Statistical analysis of the Transwell invasion assay results. *P<0.05 vs. mimic-Con, **P<0.01 vs. mimic-Con. miR-150, microRNA-150; mimic-Con, <t>negative</t> <t>control</t> transfection; OD, optical density.
Lentiviruses Designed For Overexpressing Mettl16 And Senp3, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/negative+control+sequence/shrna+sequences+targeting+mettl16+and+ppar%CE%B3++and+non+targeting+negative+control++sh+nc+/pm39218945-61-11-29
Average 90 stars, based on 1 article reviews
lentiviruses designed for overexpressing mettl16 and senp3 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Genechem lentiviral plasmid carrying gfp and a negative control sequence
Upregulation of <t>miR-150</t> suppresses human papillary thyroid carcinoma cell proliferation and metastasis. (A) Relative miR-150 expression in TPC-1 cells following transfection. (B) Proliferation of TPC-1 cells following transfection. (C) Representative micrographs of a wound-healing assay in TPC-1 cells following transfection (Scale bars=50 µm). (D) Representative micrographs of Transwell invasion experiments in TPC-1 cells following transfection (Scale bars=50 µm). (E) Statistical analysis of the wound-healing assay results. (F) Statistical analysis of the Transwell invasion assay results. *P<0.05 vs. mimic-Con, **P<0.01 vs. mimic-Con. miR-150, microRNA-150; mimic-Con, <t>negative</t> <t>control</t> transfection; OD, optical density.
Lentiviral Plasmid Carrying Gfp And A Negative Control Sequence, supplied by Genechem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/negative+control+sequence/lentiviral+plasmid+carrying+gfp+and+a+negative+control+sequence/pm36805498-52-27-30
Average 90 stars, based on 1 article reviews
lentiviral plasmid carrying gfp and a negative control sequence - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma sequences and plasmids for umuc-3 transfection si- negative control (nc)
Upregulation of <t>miR-150</t> suppresses human papillary thyroid carcinoma cell proliferation and metastasis. (A) Relative miR-150 expression in TPC-1 cells following transfection. (B) Proliferation of TPC-1 cells following transfection. (C) Representative micrographs of a wound-healing assay in TPC-1 cells following transfection (Scale bars=50 µm). (D) Representative micrographs of Transwell invasion experiments in TPC-1 cells following transfection (Scale bars=50 µm). (E) Statistical analysis of the wound-healing assay results. (F) Statistical analysis of the Transwell invasion assay results. *P<0.05 vs. mimic-Con, **P<0.01 vs. mimic-Con. miR-150, microRNA-150; mimic-Con, <t>negative</t> <t>control</t> transfection; OD, optical density.
Sequences And Plasmids For Umuc 3 Transfection Si Negative Control (Nc), supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/negative+control+sequence/sequences+and+plasmids+for+umuc+3+transfection+si++negative+control++nc+/pmc06861677-219-3-24
Average 90 stars, based on 1 article reviews
sequences and plasmids for umuc-3 transfection si- negative control (nc) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Becton Dickinson negative control short-hairpin rna sequence
Upregulation of <t>miR-150</t> suppresses human papillary thyroid carcinoma cell proliferation and metastasis. (A) Relative miR-150 expression in TPC-1 cells following transfection. (B) Proliferation of TPC-1 cells following transfection. (C) Representative micrographs of a wound-healing assay in TPC-1 cells following transfection (Scale bars=50 µm). (D) Representative micrographs of Transwell invasion experiments in TPC-1 cells following transfection (Scale bars=50 µm). (E) Statistical analysis of the wound-healing assay results. (F) Statistical analysis of the Transwell invasion assay results. *P<0.05 vs. mimic-Con, **P<0.01 vs. mimic-Con. miR-150, microRNA-150; mimic-Con, <t>negative</t> <t>control</t> transfection; OD, optical density.
Negative Control Short Hairpin Rna Sequence, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/negative+control+sequence/negative+control+short+hairpin+rna+sequence/pmc01533874-317-2-7
Average 90 stars, based on 1 article reviews
negative control short-hairpin rna sequence - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma mismatched sequence negative control oligonucleotides
Upregulation of <t>miR-150</t> suppresses human papillary thyroid carcinoma cell proliferation and metastasis. (A) Relative miR-150 expression in TPC-1 cells following transfection. (B) Proliferation of TPC-1 cells following transfection. (C) Representative micrographs of a wound-healing assay in TPC-1 cells following transfection (Scale bars=50 µm). (D) Representative micrographs of Transwell invasion experiments in TPC-1 cells following transfection (Scale bars=50 µm). (E) Statistical analysis of the wound-healing assay results. (F) Statistical analysis of the Transwell invasion assay results. *P<0.05 vs. mimic-Con, **P<0.01 vs. mimic-Con. miR-150, microRNA-150; mimic-Con, <t>negative</t> <t>control</t> transfection; OD, optical density.
Mismatched Sequence Negative Control Oligonucleotides, supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/negative+control+sequence/mismatched+sequence+negative+control+oligonucleotides/pm28529243-52-5-14
Average 90 stars, based on 1 article reviews
mismatched sequence negative control oligonucleotides - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Sangon Biotech negative control dna sequence 5′-fam-ctaagtctgaaacattacagcttgctacacgagaagagccgcacgagaaccct
Upregulation of <t>miR-150</t> suppresses human papillary thyroid carcinoma cell proliferation and metastasis. (A) Relative miR-150 expression in TPC-1 cells following transfection. (B) Proliferation of TPC-1 cells following transfection. (C) Representative micrographs of a wound-healing assay in TPC-1 cells following transfection (Scale bars=50 µm). (D) Representative micrographs of Transwell invasion experiments in TPC-1 cells following transfection (Scale bars=50 µm). (E) Statistical analysis of the wound-healing assay results. (F) Statistical analysis of the Transwell invasion assay results. *P<0.05 vs. mimic-Con, **P<0.01 vs. mimic-Con. miR-150, microRNA-150; mimic-Con, <t>negative</t> <t>control</t> transfection; OD, optical density.
Negative Control Dna Sequence 5′ Fam Ctaagtctgaaacattacagcttgctacacgagaagagccgcacgagaaccct, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/negative+control+sequence/negative+control+dna+sequence+5++fam+ctaagtctgaaacattacagcttgctacacgagaagagccgcacgagaaccct/pmc10146092-135-9-17
Average 90 stars, based on 1 article reviews
negative control dna sequence 5′-fam-ctaagtctgaaacattacagcttgctacacgagaagagccgcacgagaaccct - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Sangon Biotech adenoviruses carrying nonsense sequence (negative control, nc)
Upregulation of <t>miR-150</t> suppresses human papillary thyroid carcinoma cell proliferation and metastasis. (A) Relative miR-150 expression in TPC-1 cells following transfection. (B) Proliferation of TPC-1 cells following transfection. (C) Representative micrographs of a wound-healing assay in TPC-1 cells following transfection (Scale bars=50 µm). (D) Representative micrographs of Transwell invasion experiments in TPC-1 cells following transfection (Scale bars=50 µm). (E) Statistical analysis of the wound-healing assay results. (F) Statistical analysis of the Transwell invasion assay results. *P<0.05 vs. mimic-Con, **P<0.01 vs. mimic-Con. miR-150, microRNA-150; mimic-Con, <t>negative</t> <t>control</t> transfection; OD, optical density.
Adenoviruses Carrying Nonsense Sequence (Negative Control, Nc), supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/negative+control+sequence/adenoviruses+carrying+nonsense+sequence++negative+control++nc+/pmc11787690-43-6-19
Average 90 stars, based on 1 article reviews
adenoviruses carrying nonsense sequence (negative control, nc) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Shanghai GenePharma small interfering rnas (sirnas) of circglis2 back splicing junction sequences and negative control (nc)
Upregulation of <t>miR-150</t> suppresses human papillary thyroid carcinoma cell proliferation and metastasis. (A) Relative miR-150 expression in TPC-1 cells following transfection. (B) Proliferation of TPC-1 cells following transfection. (C) Representative micrographs of a wound-healing assay in TPC-1 cells following transfection (Scale bars=50 µm). (D) Representative micrographs of Transwell invasion experiments in TPC-1 cells following transfection (Scale bars=50 µm). (E) Statistical analysis of the wound-healing assay results. (F) Statistical analysis of the Transwell invasion assay results. *P<0.05 vs. mimic-Con, **P<0.01 vs. mimic-Con. miR-150, microRNA-150; mimic-Con, <t>negative</t> <t>control</t> transfection; OD, optical density.
Small Interfering Rnas (Sirnas) Of Circglis2 Back Splicing Junction Sequences And Negative Control (Nc), supplied by Shanghai GenePharma, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/negative+control+sequence/small+interfering+rnas++sirnas++of+circglis2+back+splicing+junction+sequences+and+negative+control++nc+/pm39370077-79-4-19
Average 90 stars, based on 1 article reviews
small interfering rnas (sirnas) of circglis2 back splicing junction sequences and negative control (nc) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


PFN1 is correlated with NSCLC metastasis and could promote NSCLC cell migration in vitro . (A) Representative IHC images of PFN1 expression on the NSCLC tissues. (B) The staining index of PFN1 on the tissue chip. ** p < 0.01. (C) Representative IHC images of PFN1 expression on the tissue chip. (D) The expression of PFN1 in TCGA LUAD data. ** p < 0.01. (E) The Kaplan–Meier survival analysis of PFN1 in NSCLC patients. (Data source: TCGA LUAD dataset) (F,G) Wound healing assays conducted to evaluate the migration ability of PFN1 -overexpressing (F) and PFN1 knockdown (KD) (G) H1299 cells. ** p < 0.01; scale bar, 500 μm. (H,I) Transwell migration assays conducted to evaluate the migration of PFN1 -overexpressing (H) and PFN1 KD (I) H1299 cells. ** p < 0.01; scale bar, 500 μm. EV, empty vector; OE, PFN1 overexpression; NC, negative control; si-1/ 2, PFN1 siRNA1 1/2.

Journal: Frontiers in Pharmacology

Article Title: Profilin 1 Induces Tumor Metastasis by Promoting Microvesicle Secretion Through the ROCK 1/p-MLC Pathway in Non-Small Cell Lung Cancer

doi: 10.3389/fphar.2022.890891

Figure Lengend Snippet: PFN1 is correlated with NSCLC metastasis and could promote NSCLC cell migration in vitro . (A) Representative IHC images of PFN1 expression on the NSCLC tissues. (B) The staining index of PFN1 on the tissue chip. ** p < 0.01. (C) Representative IHC images of PFN1 expression on the tissue chip. (D) The expression of PFN1 in TCGA LUAD data. ** p < 0.01. (E) The Kaplan–Meier survival analysis of PFN1 in NSCLC patients. (Data source: TCGA LUAD dataset) (F,G) Wound healing assays conducted to evaluate the migration ability of PFN1 -overexpressing (F) and PFN1 knockdown (KD) (G) H1299 cells. ** p < 0.01; scale bar, 500 μm. (H,I) Transwell migration assays conducted to evaluate the migration of PFN1 -overexpressing (H) and PFN1 KD (I) H1299 cells. ** p < 0.01; scale bar, 500 μm. EV, empty vector; OE, PFN1 overexpression; NC, negative control; si-1/ 2, PFN1 siRNA1 1/2.

Article Snippet: PFN1 siRNA and control scramble siRNA were synthesized by Guangzhou RiboBio Co. (Guangzhou, China), and the sequences are listed in .

Techniques: Migration, In Vitro, Expressing, Staining, Knockdown, Plasmid Preparation, Over Expression, Negative Control

PFN1 could promote MVs secretion in NSCLC. (A) Heatmap of differentially expressed proteins between EV and PFN1 OE cells. (B) GO enrichment analysis of differentially expressed proteins. (C) COG/KOG analysis of differentially expressed proteins. (D) MVs extracted from EV-expressing and PFN1 -overexpressing cells, using continuous differential centrifugation, identified using transmission electron microscopy. Scale bar, 100 nm. (E,F) Flow cytometry (E) and western blotting (F) were used to quantify MVs in PFN1 -overexpressing and EV-expressing cells. ARF6 and actin were used as MV markers. (G) Expression of PFN1 and annexin A1 in lung tumor tissues detected using immunofluorescence. (H) The staining index of p-MLC on the tissue chip. ** p < 0.01. (I) Representative IHC images of p-MLC expression. (J) Spearman rank correlation analysis was used to assess the relationship between PFN1 and p-MLC expression on the tissue chip; p and r values are shown in the plot.

Journal: Frontiers in Pharmacology

Article Title: Profilin 1 Induces Tumor Metastasis by Promoting Microvesicle Secretion Through the ROCK 1/p-MLC Pathway in Non-Small Cell Lung Cancer

doi: 10.3389/fphar.2022.890891

Figure Lengend Snippet: PFN1 could promote MVs secretion in NSCLC. (A) Heatmap of differentially expressed proteins between EV and PFN1 OE cells. (B) GO enrichment analysis of differentially expressed proteins. (C) COG/KOG analysis of differentially expressed proteins. (D) MVs extracted from EV-expressing and PFN1 -overexpressing cells, using continuous differential centrifugation, identified using transmission electron microscopy. Scale bar, 100 nm. (E,F) Flow cytometry (E) and western blotting (F) were used to quantify MVs in PFN1 -overexpressing and EV-expressing cells. ARF6 and actin were used as MV markers. (G) Expression of PFN1 and annexin A1 in lung tumor tissues detected using immunofluorescence. (H) The staining index of p-MLC on the tissue chip. ** p < 0.01. (I) Representative IHC images of p-MLC expression. (J) Spearman rank correlation analysis was used to assess the relationship between PFN1 and p-MLC expression on the tissue chip; p and r values are shown in the plot.

Article Snippet: PFN1 siRNA and control scramble siRNA were synthesized by Guangzhou RiboBio Co. (Guangzhou, China), and the sequences are listed in .

Techniques: Expressing, Centrifugation, Transmission Assay, Electron Microscopy, Flow Cytometry, Western Blot, Immunofluorescence, Staining

MVs derived from PFN1 OE cells promote migration in NSCLC cells. (A) MVs collected from sera of patients with NSCLC quantified using flow cytometry. ** p < 0.01. (B) Protein expression of ARF6 and β-actin in MVs collected from sera of patients with NSCLC detected using western blotting. (C) Effect of PFN1 -overexpressing cell supernatants on cell migration evaluated through wound healing assays. ** p < 0.01; scale bar, 500 μm. (D) PKH67-labeled MVs taken up by H1299 cells. DAPI was used to stain the nuclei of H1299 cells. Scale bar, 500 μm. (E,F) Wound healing (E) and Transwell migration (F) assays conducted to evaluate the migration of H1299 cells after treatment with MVs derived from EV-expressing and PFN1 -overexpressing cells; ** p < 0.01; scale bar, 500 μm.

Journal: Frontiers in Pharmacology

Article Title: Profilin 1 Induces Tumor Metastasis by Promoting Microvesicle Secretion Through the ROCK 1/p-MLC Pathway in Non-Small Cell Lung Cancer

doi: 10.3389/fphar.2022.890891

Figure Lengend Snippet: MVs derived from PFN1 OE cells promote migration in NSCLC cells. (A) MVs collected from sera of patients with NSCLC quantified using flow cytometry. ** p < 0.01. (B) Protein expression of ARF6 and β-actin in MVs collected from sera of patients with NSCLC detected using western blotting. (C) Effect of PFN1 -overexpressing cell supernatants on cell migration evaluated through wound healing assays. ** p < 0.01; scale bar, 500 μm. (D) PKH67-labeled MVs taken up by H1299 cells. DAPI was used to stain the nuclei of H1299 cells. Scale bar, 500 μm. (E,F) Wound healing (E) and Transwell migration (F) assays conducted to evaluate the migration of H1299 cells after treatment with MVs derived from EV-expressing and PFN1 -overexpressing cells; ** p < 0.01; scale bar, 500 μm.

Article Snippet: PFN1 siRNA and control scramble siRNA were synthesized by Guangzhou RiboBio Co. (Guangzhou, China), and the sequences are listed in .

Techniques: Derivative Assay, Migration, Flow Cytometry, Expressing, Western Blot, Labeling, Staining

PFN1 promotes in vivo NSCLC metastasis by elevating MV secretion. (A) Schematic illustration of the mouse model of metastatic tumor established to determine the role of PFN1 in tumor metastasis. (B) Body weight changes in mice after intracardiac injection of PFN1 -overexpressing and EV-expressing cell lines. (C,D) Representative images of lung (C) and liver (D) metastases of the mouse model. The number of metastases is displayed in the right-hand side graph. * p < 0.05, ** p < 0.01. (E) Representative images of HE-stained lung tissues of the mouse model. (F) Representative IHC images of PFN1 and p-MLC expression in lung tissues. The staining index is shown in the right-hand side graph. ** p < 0.01. (G) Representative images of HE-stained liver tissues of the mouse model. (H) Representative IHC images of PFN1 and p-MLC expression in liver tissues. The staining index is shown in the right-hand side graph. ** p < 0.01. (I) Body weight changes in mice after intracardiac injection of H1299 cells and MVs. (J) Representative images of lung metastases of the mouse model. The number of metastases is shown in the bottom graph. * p < 0.05. (K) Representative images of HE-stained lung tissues of the mouse model. (L) Representative IHC images of PFN1 and p-MLC expression in lung tissues. The staining index is shown in the right-hand side graph; * p < 0.05.

Journal: Frontiers in Pharmacology

Article Title: Profilin 1 Induces Tumor Metastasis by Promoting Microvesicle Secretion Through the ROCK 1/p-MLC Pathway in Non-Small Cell Lung Cancer

doi: 10.3389/fphar.2022.890891

Figure Lengend Snippet: PFN1 promotes in vivo NSCLC metastasis by elevating MV secretion. (A) Schematic illustration of the mouse model of metastatic tumor established to determine the role of PFN1 in tumor metastasis. (B) Body weight changes in mice after intracardiac injection of PFN1 -overexpressing and EV-expressing cell lines. (C,D) Representative images of lung (C) and liver (D) metastases of the mouse model. The number of metastases is displayed in the right-hand side graph. * p < 0.05, ** p < 0.01. (E) Representative images of HE-stained lung tissues of the mouse model. (F) Representative IHC images of PFN1 and p-MLC expression in lung tissues. The staining index is shown in the right-hand side graph. ** p < 0.01. (G) Representative images of HE-stained liver tissues of the mouse model. (H) Representative IHC images of PFN1 and p-MLC expression in liver tissues. The staining index is shown in the right-hand side graph. ** p < 0.01. (I) Body weight changes in mice after intracardiac injection of H1299 cells and MVs. (J) Representative images of lung metastases of the mouse model. The number of metastases is shown in the bottom graph. * p < 0.05. (K) Representative images of HE-stained lung tissues of the mouse model. (L) Representative IHC images of PFN1 and p-MLC expression in lung tissues. The staining index is shown in the right-hand side graph; * p < 0.05.

Article Snippet: PFN1 siRNA and control scramble siRNA were synthesized by Guangzhou RiboBio Co. (Guangzhou, China), and the sequences are listed in .

Techniques: In Vivo, Injection, Expressing, Staining

Mechanisms underlying the promotion of MLC phosphorylation by PFN1. (A,B) Protein expression after PFN1 overexpression (A) and knockdown (B) measured using western blotting. (C) Protein expression in PFN1 mutants measured using western blotting. (D) PFN1 interactions with ROCK1/2 confirmed using co-IP. (E) Protein expression after treatment with Y27632 (10 µM) measured using western blotting. (F) Effect of PFN1 on ROCK1 activity. ** p < 0.01. (G) Effect of PFN1 on ROCK2 activity. (H) Flow cytometry measuring changes in the amount of MVs after treatment with Y27632; * p < 0.05.

Journal: Frontiers in Pharmacology

Article Title: Profilin 1 Induces Tumor Metastasis by Promoting Microvesicle Secretion Through the ROCK 1/p-MLC Pathway in Non-Small Cell Lung Cancer

doi: 10.3389/fphar.2022.890891

Figure Lengend Snippet: Mechanisms underlying the promotion of MLC phosphorylation by PFN1. (A,B) Protein expression after PFN1 overexpression (A) and knockdown (B) measured using western blotting. (C) Protein expression in PFN1 mutants measured using western blotting. (D) PFN1 interactions with ROCK1/2 confirmed using co-IP. (E) Protein expression after treatment with Y27632 (10 µM) measured using western blotting. (F) Effect of PFN1 on ROCK1 activity. ** p < 0.01. (G) Effect of PFN1 on ROCK2 activity. (H) Flow cytometry measuring changes in the amount of MVs after treatment with Y27632; * p < 0.05.

Article Snippet: PFN1 siRNA and control scramble siRNA were synthesized by Guangzhou RiboBio Co. (Guangzhou, China), and the sequences are listed in .

Techniques: Phospho-proteomics, Expressing, Over Expression, Knockdown, Western Blot, Co-Immunoprecipitation Assay, Activity Assay, Flow Cytometry

ROCK1 inhibitor Y27632 partially reversed the promotion of lung cancer metastasis by PFN1 in vitro and in vivo . (A,B) Wound healing assays conducted to evaluate the effect of Y27632 (A) and Y27632 combined with MVs (B) on cell migration. ** p < 0.01; scale bar, 500 μm. (C) Transwell migration assays conducted to evaluate the effect of Y27632 and Y27632 combined with MVs on cell migration. ** p < 0.01; scale bar, 500 μm. (D) Schematic diagram of the mouse model of metastatic tumor established to determine the effect of Y27632 on PFN1-induced lung cancer metastasis. (E) Body weight changes in mice after intracardiac injection of PFN1 -overexpressing H1299 cells and intraperitoneal injection of Y27632 (10 mg/kg). (F) Representative images of lung and liver metastatic tissue in mice. The number of metastatic nodules is shown in the right-hand side graph. * p < 0.05. (G,H) Representative images of HE-stained lung (G) and liver (H) metastases. (I) Representative IHC images of PFN1 and p-MLC expression in lung tissues. The staining index is shown in the right-hand side graph. ** p < 0.01. (J) Representative IHC images of PFN1 and p-MLC expression in liver tissues. The staining index is shown in the right-hand side graph; ** p < 0.01.

Journal: Frontiers in Pharmacology

Article Title: Profilin 1 Induces Tumor Metastasis by Promoting Microvesicle Secretion Through the ROCK 1/p-MLC Pathway in Non-Small Cell Lung Cancer

doi: 10.3389/fphar.2022.890891

Figure Lengend Snippet: ROCK1 inhibitor Y27632 partially reversed the promotion of lung cancer metastasis by PFN1 in vitro and in vivo . (A,B) Wound healing assays conducted to evaluate the effect of Y27632 (A) and Y27632 combined with MVs (B) on cell migration. ** p < 0.01; scale bar, 500 μm. (C) Transwell migration assays conducted to evaluate the effect of Y27632 and Y27632 combined with MVs on cell migration. ** p < 0.01; scale bar, 500 μm. (D) Schematic diagram of the mouse model of metastatic tumor established to determine the effect of Y27632 on PFN1-induced lung cancer metastasis. (E) Body weight changes in mice after intracardiac injection of PFN1 -overexpressing H1299 cells and intraperitoneal injection of Y27632 (10 mg/kg). (F) Representative images of lung and liver metastatic tissue in mice. The number of metastatic nodules is shown in the right-hand side graph. * p < 0.05. (G,H) Representative images of HE-stained lung (G) and liver (H) metastases. (I) Representative IHC images of PFN1 and p-MLC expression in lung tissues. The staining index is shown in the right-hand side graph. ** p < 0.01. (J) Representative IHC images of PFN1 and p-MLC expression in liver tissues. The staining index is shown in the right-hand side graph; ** p < 0.01.

Article Snippet: PFN1 siRNA and control scramble siRNA were synthesized by Guangzhou RiboBio Co. (Guangzhou, China), and the sequences are listed in .

Techniques: In Vitro, In Vivo, Migration, Injection, Staining, Expressing

Schematic diagram of the role of PFN1 in NSCLC metastasis. In the initiation stage of NSCLC, cells with upregulated PFN1 secret more MVs through PFN1 interactions with the ROCK/p-MLC pathway. These MVs contain numerous oncogenenic moleculars, which could enhance migration abilities of PFN1 normal expressed NSCLC cells, and untimately promote progression and metastasis of NSCLC.

Journal: Frontiers in Pharmacology

Article Title: Profilin 1 Induces Tumor Metastasis by Promoting Microvesicle Secretion Through the ROCK 1/p-MLC Pathway in Non-Small Cell Lung Cancer

doi: 10.3389/fphar.2022.890891

Figure Lengend Snippet: Schematic diagram of the role of PFN1 in NSCLC metastasis. In the initiation stage of NSCLC, cells with upregulated PFN1 secret more MVs through PFN1 interactions with the ROCK/p-MLC pathway. These MVs contain numerous oncogenenic moleculars, which could enhance migration abilities of PFN1 normal expressed NSCLC cells, and untimately promote progression and metastasis of NSCLC.

Article Snippet: PFN1 siRNA and control scramble siRNA were synthesized by Guangzhou RiboBio Co. (Guangzhou, China), and the sequences are listed in .

Techniques: Migration

Upregulation of miR-150 suppresses human papillary thyroid carcinoma cell proliferation and metastasis. (A) Relative miR-150 expression in TPC-1 cells following transfection. (B) Proliferation of TPC-1 cells following transfection. (C) Representative micrographs of a wound-healing assay in TPC-1 cells following transfection (Scale bars=50 µm). (D) Representative micrographs of Transwell invasion experiments in TPC-1 cells following transfection (Scale bars=50 µm). (E) Statistical analysis of the wound-healing assay results. (F) Statistical analysis of the Transwell invasion assay results. *P<0.05 vs. mimic-Con, **P<0.01 vs. mimic-Con. miR-150, microRNA-150; mimic-Con, negative control transfection; OD, optical density.

Journal: Experimental and Therapeutic Medicine

Article Title: MicroRNA-150 suppresses the growth and malignant behavior of papillary thyroid carcinoma cells via downregulation of MUC4

doi: 10.3892/etm.2018.6197

Figure Lengend Snippet: Upregulation of miR-150 suppresses human papillary thyroid carcinoma cell proliferation and metastasis. (A) Relative miR-150 expression in TPC-1 cells following transfection. (B) Proliferation of TPC-1 cells following transfection. (C) Representative micrographs of a wound-healing assay in TPC-1 cells following transfection (Scale bars=50 µm). (D) Representative micrographs of Transwell invasion experiments in TPC-1 cells following transfection (Scale bars=50 µm). (E) Statistical analysis of the wound-healing assay results. (F) Statistical analysis of the Transwell invasion assay results. *P<0.05 vs. mimic-Con, **P<0.01 vs. mimic-Con. miR-150, microRNA-150; mimic-Con, negative control transfection; OD, optical density.

Article Snippet: miR-150 mimics (5′-UCUCCCAACCCUUGUACCAGUG-3′) and negative control miR sequences (5′-CCGAAACCUCGGUUGAUUGCGG-3′) were purchased from Shanghai GenePharma Co., Ltd. (Shanghai, China).

Techniques: Expressing, Transfection, Wound Healing Assay, Transwell Invasion Assay, Negative Control

MUC4 is a direct target of miR-150 in papillary thyroid carcinoma cells. (A) miR-150 and its target site in MUC4 3′-UTR. The mutant bases are indicated by boxes. (B) Luciferase reporter assay in TPC-1 cells transfected with reporter vectors containing WT or MUT MUC4 3′-UTR. (C) MUC4 mRNA expression was evaluated by reverse transcription-quantitative polymerase chain reaction in TPC-1 cells transfected with miR-150 mimics and mimic-Con. (D) MUC4 protein expression was evaluated by western blot analysis in TPC-1 cells transfected with miR-150 mimics and mimic-Con. (E) Densitometric analysis of MUC4 protein level. *P<0.05 vs. control; **P<0.01 vs. mimic-Con. miR-150, microRNA-150; mimic-Con, negative control transfection; MUC4, mucin 4; 3′-UTR, 3′-untranslated region; NC, negative control; WT, wild type; MUT, mutated.

Journal: Experimental and Therapeutic Medicine

Article Title: MicroRNA-150 suppresses the growth and malignant behavior of papillary thyroid carcinoma cells via downregulation of MUC4

doi: 10.3892/etm.2018.6197

Figure Lengend Snippet: MUC4 is a direct target of miR-150 in papillary thyroid carcinoma cells. (A) miR-150 and its target site in MUC4 3′-UTR. The mutant bases are indicated by boxes. (B) Luciferase reporter assay in TPC-1 cells transfected with reporter vectors containing WT or MUT MUC4 3′-UTR. (C) MUC4 mRNA expression was evaluated by reverse transcription-quantitative polymerase chain reaction in TPC-1 cells transfected with miR-150 mimics and mimic-Con. (D) MUC4 protein expression was evaluated by western blot analysis in TPC-1 cells transfected with miR-150 mimics and mimic-Con. (E) Densitometric analysis of MUC4 protein level. *P<0.05 vs. control; **P<0.01 vs. mimic-Con. miR-150, microRNA-150; mimic-Con, negative control transfection; MUC4, mucin 4; 3′-UTR, 3′-untranslated region; NC, negative control; WT, wild type; MUT, mutated.

Article Snippet: miR-150 mimics (5′-UCUCCCAACCCUUGUACCAGUG-3′) and negative control miR sequences (5′-CCGAAACCUCGGUUGAUUGCGG-3′) were purchased from Shanghai GenePharma Co., Ltd. (Shanghai, China).

Techniques: Mutagenesis, Luciferase, Reporter Assay, Transfection, Expressing, Reverse Transcription, Real-time Polymerase Chain Reaction, Western Blot, Control, Negative Control

Effect of miR-150 on HER2 and downstream FAK/ERK signaling. (A) Protein levels were evaluated by western blot analysis. (B) Densitometric analysis of each protein level. **P<0.01 vs. mimic-Con. miR-150, microRNA-150; mimic-Con, negative control transfection; HER2, human epidermal growth factor receptor 2; FAK, focal adhesion kinase; ERK, extracellular signal-regulated kinase.

Journal: Experimental and Therapeutic Medicine

Article Title: MicroRNA-150 suppresses the growth and malignant behavior of papillary thyroid carcinoma cells via downregulation of MUC4

doi: 10.3892/etm.2018.6197

Figure Lengend Snippet: Effect of miR-150 on HER2 and downstream FAK/ERK signaling. (A) Protein levels were evaluated by western blot analysis. (B) Densitometric analysis of each protein level. **P<0.01 vs. mimic-Con. miR-150, microRNA-150; mimic-Con, negative control transfection; HER2, human epidermal growth factor receptor 2; FAK, focal adhesion kinase; ERK, extracellular signal-regulated kinase.

Article Snippet: miR-150 mimics (5′-UCUCCCAACCCUUGUACCAGUG-3′) and negative control miR sequences (5′-CCGAAACCUCGGUUGAUUGCGG-3′) were purchased from Shanghai GenePharma Co., Ltd. (Shanghai, China).

Techniques: Western Blot, Negative Control, Transfection